In response to the continuing COVID-19 crisis, regulatory authorities have focused on providing support for the rapid development of vaccines and treatments and the expedited approval and implementation of agile regulatory systems.
The NIFDS-DIA Workshop 2021 will explore the theme of “Facilitating the Development and Regulations of COVID-19 Vaccines and Treatments / Current Trends in New Drug Developments and Regulations.”
Who should attend?
- Industry professionals in Pharmaceuticals involved in Research & Development, Regulatory Affairs, Medical Affairs and Clinical Studies
- Regulators and personnel from Health Authorities and Ministries
- Academia and Researchers
NIFDS and DIA jointly offer you an opportunity to share experiences of systematic and effective response to the global crisis caused by the COVID-19 pandemic. We will invite former and current regulators in the FDA and EMA as well as experts from the pharmaceutical industry who have hands-on experiences.
We will also hear from speakers about innovative drug development, tools used and legal strategies.
Hae-Young Ahn, PhD • President
Ahn Bio, United States
SoHee Kim, PhD • Director / Pharmacist, Ministry of Food and Drug Safety
National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of
Younglim Kim, PhD • Director
NIFDS, Korea, Republic of
Jeewon Joung, PhD • Deputy Director
Korean Ministry of Food and Drug Safety (MFDS) , Korea, Republic of
Junesik Mune, MD, PhD • VP, Clinical & Regulatory Affairs Center
LG Chem, Korea, Republic of
Rok Song • Research Scientist
IVI, Korea, Republic of
Kyung Won Seo • Director General, National Institute of Food and Drug Safety Evaluation
Ministiry of Food and Drug Safety, Korea, Republic of
Younjoo Park • Director, General of Department
MFDS, Korea, Republic of
In-sook Park • Director, Gastroenterology and Metabolism Product Div, Drug Evaluation Dept
Ministry of Food and Drug Safety, Korea, Republic of